Global Cardiac Pacemakers market overview 2024, Forecast To 2033
26 Jan, 2024
The cardiac pacemakers market has shown strong growth, increasing from $4.58 billion in 2023 to $4.86 billion in 2024, with a CAGR of 6.1%. This growth in the historic period is attributed to the aging population, prevalence of cardiovascular diseases, growing awareness of arrhythmias, investment in R&D for pacemaker innovation, evolving healthcare infrastructure, and regulatory approvals for novel pacemaker features. Moving forward, the market is expected to experience strong growth, reaching $6.14 billion in 2028, with a CAGR of 6.1%. Factors contributing to this growth include a focus on lead durability, reduction of complications, remote programming and telehealth services, expansion of emerging markets, enhanced battery technologies, and regulatory support for expedited pacemaker approvals. Major trends in the forecast period include electrophysiology advancements, integration of pacemaker data into electronic health records, integration of AI for predictive maintenance, advancements in pacemaker technology, and telemedicine and remote monitoring.
Global Cardiac Pacemakers Market Key Driver
The cardiac pacemaker market sees significant growth due to the increasing incidence of cardiovascular diseases. In September 2023, the World Health Organization reported 17.9 million deaths from cardiovascular diseases annually, constituting 74% of non-communicable disease-related deaths. The rising incidence of cardiovascular diseases drives the growth of the cardiac pacemaker market.
Get A Free Sample Of The Global Cardiac Pacemakers Market ReportGlobal Cardiac Pacemakers Market Segments
The global cardiac pacemakers market covered in this report is segmented –
1) By Type: Implantable, External
2) By Technology: Biventricular, Single Chambered, Dual Chambered
3) By Application: Arrhythmias, Heart Blockage, Atrial Fibrillation, Long QT Syndrome, Congestive Cardiac Failure, Other Applications
4) By End User: Clinics And Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers
Major Cardiac Pacemakers Industry Players
Medtronic plc, Lepu Medical Technology Co., Abbott Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, Oscor Inc., Osypca Medical GmbH, Zoll Medical Corporation, MicroPort Scientific Corporation, Cook Group Incorporated, Sorin Group, Vitatron & Medical Co., Cordis Inc., Shree Pacetronix Limited, Medico SpA, St. Jude Medical, LivaNova PLC, Schiller AG, BTL Industries Inc., CCC Medical Devices, Cardiostim, Advena Ltd., Mediana Co. Ltd., Vimecon GmbH, Cardiac Science Corporation, Greatbatch Medical, Galix Biomedical Instrumentation, Nanjing MicroPort Medical, A&E Medical Corporation, Cardionovum GmbH
Get The Full Global Cardiac Pacemakers Market Report
Cardiac Pacemakers Market Overview
A cardiac pacemaker refers to a small electronic device that generates electrical impulses and prevents the heart from beating too fast or slow and helps in treating heart conditions such as arrhythmias is a heart condition where the heart beats irregularly. The cardiac pacemakers are used to maintain the rhythm of heartbeats.
Cardiac Pacemakers Global Market Report 2023 provides data on the global cardiac pacemakers market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The cardiac pacemakers market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.